InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: wjlknew post# 4960

Sunday, 03/18/2007 2:51:29 AM

Sunday, March 18, 2007 2:51:29 AM

Post# of 6490
wjlk,

Seems fairly clear, Insmed has licensed INSM-18 for some target indications to NAPO for $1.5 million plus milestones and royalties. Insmed has retained rights to all other indications such as cancer which they are working on with UCSF.
As with all things Insmed, you have to dig to keep up with what is going on since their IR-PR sucks. This is getting old isn't it?

Rod

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News